By Robert Cantrell One of the least likely ways to succeed with IP may be to be an IP creator. The reason for this is because of the highly speculative nature of idea creation. It can leave the IP creator in a poor bargaining position before he creates a new solution, given the high probability […]
Make Money (and Don’t Waste It)!
October 26, 2012 by Leave a Comment
By Lily Li Patents have intrinsic value beyond their contribution to your company’s product lines. After all, patents are the physical embodiment of your company’s technological genius, just as stocks and bonds embody the value of your company’s other intangible assets. Instead of letting your patents go to waste, treat your patent portfolio like your […]
The Disclosure Revolution: It’s a WYDIWYG World
October 25, 2012 by Leave a Comment
By Joseph E. Root This post is excerpted, in modified form, from Rules of Patent Drafting: Guidelines from Federal Circuit Case Law (2010), © 2010, Oxford University Press, Inc. There was a time when patent lawyers were magicians and their bags of tricks were filled with claim drafting tools. Write “a widget,” and shazam! “a widget” […]
Research Liasion: Corporate – University Research Alliances
October 23, 2012 by Leave a Comment
By Michael D. Moberly A ‘research liaison’ should contribute to corporate – university (sponsored) research projects by: sustaining (protecting and preserving) unencumbered control, use, ownership and monitoring the value of both parties’ investments, i.e., the projected stream of intangible assets, IP, competitive advantages, and (proprietary) know how evolving from the research. Unfortunately, there’s a fairly […]
IP Strategy changing focus
October 22, 2012 by Leave a Comment
By Duncan Bucknell There was a great discussion at a recent symposium in Melbourne on ‘IP Strategy, what has changed, what is changing?’ Here are my slides – I look forward to your comments too. IP Strategy – what has changed, what is changing? from DuncanBucknell [This post originally appeared at IP Think Tank.]
Are patents a double-edged sword? Perspective Matters.
October 19, 2012 by Leave a Comment
By Girish Malhotra Patents are filed to preserve intellectual property for the duration of the patent life. This is the fundamental right of every inventor as they protect their invention from competitors and gives them competitive advantage. Pharmaceuticals have relied on this right to preserve their inventions. These patents are a treasure trove for the […]
Corporate IP Strategy – a High-Level View
October 18, 2012 by Leave a Comment
By Ian Maxwell There are two good strategic reasons why any operating company should have patents, and they both relate to financial return on investment: 1. To use a monopoly, suggested or realized by patents, to get a higher margin and/or higher revenues for products or services, and 2. For the value of the patents […]
How to build a world-class licensing programme
October 17, 2012 by Leave a Comment
By Mac Leckrone New business models and a growing anti-patent trend are changing the business of licensing. The challenge for licensing programme managers in this evolving landscape is to find ways of delivering greater value to customers. At least two ‘megatrends’ – large-scale shifts in the landscape – have the potential to change most of […]
IP Strategy for Drug Discovery: A Dedicated Research Firm’s Perspective
October 16, 2012 by Leave a Comment
By Vinita Radhakrishnan Given the nature of business of a dedicated research firm (DRF) in the pharmaceutical sector, intellectual property (IP), particularly, patents are considered to be the most valued asset. More times than not, the standing of a dedicated research firm, in the market place, is judged by the strength and nature of their […]
ipstrategy.com 